Literature DB >> 27358103

Multiple brown tumours from parathyroid carcinoma.

Daryl Jade Tardo Dagang1, Jerico Baliton Gutierrez1, Mark Anthony Santiago Sandoval1, Frances Lina Lantion-Ang1.   

Abstract

We report a case of a 29-year-old woman who suffered from severe bilateral inguinal pain and left mandibular mass. CT scan showed innumerable expansile osteolytic bone masses on the iliac wings, femur, ribs and vertebral bodies, diffuse skeletal osteopaenia, calyceal lithiasis on the right kidney and a left thyroid mass. Ionised calcium and intact parathyroid hormone (PTH) were elevated. Parathyroid sestamibi scan showed a hyperfunctioning left inferior parathyroid gland. Biopsy of the left mandibular mass was consistent with brown tumour. The patient underwent parathyroidectomy of the enlarged parathyroid gland. Final histopathology, however, revealed parathyroid carcinoma, 4.7 cm in widest dimension, with capsular and vascular space invasion. The patient underwent repeat surgery, specifically, left thyroid lobectomy, isthmectomy and central node dissection. Intact PTH decreased from 681.3 to 74 pg/mL (normal range: 10-65) 24 hours postoperatively. Follow-up at 6 months showed normal serum calcium levels, size reduction of bone lesions and improvement of quality of life. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27358103      PMCID: PMC4932410          DOI: 10.1136/bcr-2016-215961

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  26 in total

Review 1.  Clinical review 122: Parathyroid carcinoma.

Authors:  E Shane
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Extensive brown tumors caused by parathyroid adenoma in an adolescent patient.

Authors:  Mehmet Emre Atabek; Ozgur Pirgon; Ahmet Sert; H Hasan Esen
Journal:  Eur J Pediatr       Date:  2007-02-02       Impact factor: 3.183

3.  Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB).

Authors:  Elliot A Asare; Cord Sturgeon; David J Winchester; Lei Liu; Bryan Palis; Nancy D Perrier; Douglas B Evans; David P Winchester; Tracy S Wang
Journal:  Ann Surg Oncol       Date:  2015-06-16       Impact factor: 5.344

4.  Ultrasonographic features of parathyroid carcinoma.

Authors:  H Hara; A Igarashi; Y Yano; T Yashiro; E Ueno; Y Aiyoshi; K Ito; T Obara
Journal:  Endocr J       Date:  2001-04       Impact factor: 2.349

Review 5.  Clinical presentation, staging and long-term evolution of parathyroid cancer.

Authors:  Nadia Talat; Klaus-Martin Schulte
Journal:  Ann Surg Oncol       Date:  2010-03-10       Impact factor: 5.344

6.  Brown tumors of the femur and pelvis secondary to a parathyroid carcinoma: report of one case.

Authors:  Dan Radulescu; Bogdan Chis; Valer Donca; Valentin Munteanu
Journal:  Rev Med Chil       Date:  2014-07       Impact factor: 0.553

Review 7.  Diagnosis and management of parathyroid cancer.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Endocrinol       Date:  2012-07-03       Impact factor: 43.330

8.  Brown tumor of the maxillary sinus in a patient with primary hyperparathyroidism: a case report.

Authors:  Efklidis Proimos; Theognosia S Chimona; Dimetrio Tamiolakis; Michalis G Tzanakakis; Chariton E Papadakis
Journal:  J Med Case Rep       Date:  2009-07-06

9.  Giant cell tumors of bone containing large amounts of hemosiderin: MR-pathologic correlation.

Authors:  J Aoki; K Moriya; K Yamashita; F Fujioka; K Ishii; O Karakida; S Imai; F Sakai; Y Imai; S Sone
Journal:  J Comput Assist Tomogr       Date:  1991 Nov-Dec       Impact factor: 1.826

Review 10.  Parathyroid carcinoma.

Authors:  E Kebebew
Journal:  Curr Treat Options Oncol       Date:  2001-08
View more
  1 in total

1.  Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma-A Rare, Highly Malignant Subtype.

Authors:  Yongchao Yu; Yue Wang; Qingcheng Wu; Xuzi Zhao; Deshun Liu; Yongfu Zhao; Yuguo Li; Guangzhi Wang; Jingchao Xu; Junzhu Chen; Ning Zhang; Xiaofeng Tian
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-15       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.